Filing Details
- Accession Number:
- 0001110803-14-000174
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-15 20:53:51
- Reporting Period:
- 2014-05-15
- Filing Date:
- 2014-05-15
- Accepted Time:
- 2014-05-15 20:53:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1534166 | Nicholas Naclerio | 5200 Illumina Way San Diego CA 92122 | Sr Vp, Corp Develop & Gm | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-05-15 | 2,000 | $43.37 | 25,146 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-05-15 | 679 | $140.63 | 24,467 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-05-15 | 700 | $141.50 | 23,767 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-05-15 | 421 | $142.92 | 23,346 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-05-15 | 200 | $143.70 | 23,146 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-05-15 | 2,000 | $0.00 | 2,000 | $43.37 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
74,000 | 2011-08-08 | 2020-06-29 | No | 4 | M | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 679 shares sold ranging from $140.07 to $141.04 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 700 shares sold ranging from $141.23 to $141.70 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 421 shares sold ranging from $142.47 to $143.31 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 200 shares sold ranging from $143.59 to $143.81 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.